2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist

  • J Med Chem. 1996 Apr 26;39(9):1760-2. doi: 10.1021/jm950654w.
J J Hale  1 ,  S G Mills ,  M MacCoss ,  S K Shah ,  H Qi ,  D J Mathre ,  M A Cascieri ,  S Sadowski ,  C D Strader ,  D E MacIntyre ,  J M Metzger
Affiliations
  • 1. Merck Research Laboratories, Rahway, New Jersey 07065, USA.